Tuberculosis

Journal Title：Tuberculosis

Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis, notably on bacteriological, immunological and pathogenesis aspects of the disease. The journal publishes original research and reviews on the host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism, however discourages submissions with a meta-analytical focus (for example, articles based on searches of published articles in public electronic databases, especially where there is lack of evidence of the personal involvement of authors in the generation of such material). We do not publish Clinical Case-Studies.

Areas on which submissions are welcomed include:

-Clinical TrialsDiagnostics-

Antimicrobial resistance-

Immunology-

Leprosy-

Microbiology, including microbial physiology-

Molecular epidemiology-

Non-tuberculous Mycobacteria-

Pathogenesis-

Pathology-

Vaccine development.

This Journal does not accept case-reports.

The resurgence of interest in tuberculosis has accelerated the pace of relevant research and Tuberculosis has grown with it, as the only journal dedicated to experimental biomedical research in tuberculosis.

《结核病》是一本专业期刊，专注于结核病的基础实验研究，特别是该疾病的细菌学、免疫学和发病机制方面。该期刊发表关于结核病的宿主反应和免疫学以及该生物体的分子生物学、遗传学和生理学的原创研究和评论，但不鼓励以荟萃分析为重点的投稿（例如，基于对公共电子数据库中已发表文章的搜索而撰写的文章，尤其是缺乏作者个人参与此类材料生成的证据）。我们不发表临床案例研究。

欢迎投稿的领域包括：

-临床试验诊断-

抗菌素耐药性-

免疫学-

麻风病-

微生物学，包括微生物生理学-

分子流行病学-

非结核分枝杆菌-

发病机制-

病理学-

疫苗开发。

本期刊不接受病例报告。

人们对结核病兴趣的复苏加速了相关研究的步伐，Tuberculosis 也随之发展，成为唯一致力于结核病实验生物医学研究的期刊。

Tuberculosis创刊于2001年，由Churchill Livingstone出版商出版，收稿方向涵盖医学 - 呼吸系统全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 约1月 ，影响因子指数2.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。